CNS Pharmaceuticals’ $11.5 Million Public Offering

Martina Bellini
Tagged:

Schiff Hardin LLP advised CNS Pharmaceuticals, Inc. on the deal.CNS Pharmaceuticals, Inc. announced its public offering of 5,750,000 shares of common stock and 2,875,000 warrants to purchase…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now